In a very analyze in breast cancer cells, the combination of lapatinib, a dual HER2/neu and EGFR tyrosine kinase inhibitor, with INK128 prevented both HER2 and HER3 phosphorylation induced by INK128 and created synergistic induction of cell Loss of life in numerous HER2-good mobile traces proof against trastuzumab and lapatinib. https://margarets641ins5.eveowiki.com/user